Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Targets
Carla Zoja, Christodoulos Xinaris, Daniela Macconi
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy
Jing Yang, Zhangsuo Liu
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 143
Sirtuins in kidney health and disease
Luca Perico, Giuseppe Remuzzi, Ariela Benigni
Nature Reviews Nephrology (2024) Vol. 20, Iss. 5, pp. 313-329
Closed Access | Times Cited: 17
Flavonoids on diabetic nephropathy: advances and therapeutic opportunities
Qichao Hu, Caiyan Qu, Xiaolin Xiao, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 74
The Role of Oxidative Stress-Mediated Inflammation in the Development of T2DM-Induced Diabetic Nephropathy: Possible Preventive Action of Tannins and Other Oligomeric Polyphenols
Gohar Sahakyan, Anne Véjux, Naira Sahakyan
Molecules (2022) Vol. 27, Iss. 24, pp. 9035-9035
Open Access | Times Cited: 40
Diabetic complications and prospective immunotherapy
Lewis Reynolds, Zhengkang Luo, K. N. Singh
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Six-Month Periodic Fasting in Patients With Type 2 Diabetes and Diabetic Nephropathy: A Proof-of-Concept Study
Alba Sulaj, Stefan Kopf, Ekaterina von Rauchhaupt, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 8, pp. 2167-2181
Open Access | Times Cited: 37
The Nicotinamide/Streptozotocin Rodent Model of Type 2 Diabetes: Renal Pathophysiology and Redox Imbalance Features
Liang‐Jun Yan
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1225-1225
Open Access | Times Cited: 34
NADH/NAD+ Redox Imbalance and Diabetic Kidney Disease
Liang‐Jun Yan
Biomolecules (2021) Vol. 11, Iss. 5, pp. 730-730
Open Access | Times Cited: 35
Gentiopicroside Ameliorates Diabetic Renal Tubulointerstitial Fibrosis via Inhibiting the AT1R/CK2/NF-κB Pathway
Zhanchi Xu, Meng Zhang, Yu Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Activated Histone Acetyltransferase p300/CBP-Related Signalling Pathways Mediate Up-Regulation of NADPH Oxidase, Inflammation, and Fibrosis in Diabetic Kidney
Alexandra-Gela Lazar, Mihaela-Loredana Vlad, Adrian Manea, et al.
Antioxidants (2021) Vol. 10, Iss. 9, pp. 1356-1356
Open Access | Times Cited: 31
PPAR-α Agonist Fenofibrate Prevented Diabetic Nephropathy by Inhibiting M1 Macrophages via Improving Endothelial Cell Function in db/db Mice
Xiaomeng Feng, Xia Gao, Shuo Wang, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 28
Erythropoietin Mitigates Diabetic Nephropathy by Restoring PINK1/Parkin-Mediated Mitophagy
Xinyao Yi, Wenhui Yan, Tingli Guo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
SIRT1–SIRT7 in Diabetic Kidney Disease: Biological Functions and Molecular Mechanisms
Wenxiu Qi, Cheng Hu, Daqing Zhao, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
The Correlation between Thyroid Hormone Levels and the Kidney Disease Progression Risk in Patients with Type 2 Diabetes
Zhi Yang, Peng Duan, Weihong Li, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 59-67
Open Access | Times Cited: 19
Maresin 1 Alleviates Diabetic Kidney Disease via LGR6-Mediated cAMP-SOD2-ROS Pathway
Xinyue Li, Bu-tuo Xu, Jing Wu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 19
Clinical efficacy and safety of sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor, glucagon-like peptide-1 (GLP-1) receptor agonist, and Finerenone in type 2 diabetes mellitus with non-dialysis chronic kidney disease: a network meta-analysis of randomized clinical trials
Jingyi Guo, Maoying Wei, Wen‐Hua Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Interactions among Long Non-Coding RNAs and microRNAs Influence Disease Phenotype in Diabetes and Diabetic Kidney Disease
Swayam Prakash Srivastava, Julie E. Goodwin, Pratima Tripathi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6027-6027
Open Access | Times Cited: 25
Hypoxia-Inducible Factors and Diabetic Kidney Disease—How Deep Can We Go?
Alina Mihaela Stăniguţ, C Panà, Manuela Enciu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10413-10413
Open Access | Times Cited: 18
Recent advances of gut microbiota in chronic kidney disease patients
Ying‐Yong Zhao
Exploration of Medicine (2022), pp. 260-274
Open Access | Times Cited: 17
Nephroprotective effects of honokiol in a high-fat diet-streptozotocin rat model of diabetic nephropathy
Ishfaq Ahmad Rather, Nadeem Khan, Ajay Singh Kushwah, et al.
Life Sciences (2023) Vol. 320, pp. 121543-121543
Closed Access | Times Cited: 9
Urinary exosomal miRNA-663a shows variable expression in diabetic kidney disease patients with or without proteinuria
Nisha Sinha, Veena Puri, Vivek Kumar, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Baicalin Exerts a Protective Effect in Diabetic Nephropathy by Repressing Inflammation and Oxidative Stress Through the SphK1/S1P/NF-κB Signaling Pathway
Gaofei Ren, Pengfei Jiao, Yushan Yan, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 1193-1205
Open Access | Times Cited: 9
Wogonin upregulates SOCS3 to alleviate the injury in Diabetic Nephropathy by inhibiting TLR4-mediated JAK/STAT/AIM2 signaling pathway
Yufeng Liu, Mengbi Zhang, Lu Zeng, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 3
Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney disease
Swayam Prakash Srivastava, Han Zhou, Rachel Shenoi, et al.
Science Advances (2024) Vol. 10, Iss. 49
Open Access | Times Cited: 3
Proanthocyanidins Protect Against Cadmium-Induced Diabetic Nephropathy Through p38 MAPK and Keap1/Nrf2 Signaling Pathways
Pin Gong, Peipei Wang, Sihui Pi, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top